PATH three-lens brief
Evidence-based stock research on PATH. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Moved +2.84% yesterday. · Underperforming SPY by 20.2pp over 30 days.
- Moved +2.84% yesterday.
- Underperforming SPY by 20.2pp over 30 days.
- Analyst mean target $13.80 — 26% above current (16 analysts).
- Debt-to-equity of 3.9 — balance-sheet-heavy.
PATH closed at $10.97 (+2.84%) as of 2026-05-04. Market cap: $5.75B. P/E (trailing) 21.1. Positives: moved +2.84% yesterday.; analyst mean target $13.80 — 26% above current (16 analysts).. Concerns: underperforming SPY by 20.2pp over 30 days.; debt-to-equity of 3.9 — balance-sheet-heavy.. Last quarter: Revenue $481.11M, net income $104.46M, free cash flow $473.55M.
Why three lenses on PATH, not one.
A single reasoning model has blind spots it doesn’t know about. We examine PATHacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/PATH" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath PATH brief"></iframe>